STIM - ニュ―ロネティクス (Neuronetics Inc.) ニュ―ロネティクス

 STIMのチャート


 STIMの企業情報

symbol STIM
会社名 Neuronetics Inc (ニュ―ロネティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 Neuronetics Inc. is commercial-stage medical technology company. The Company is focused on the design and development of medical devices to treat psychiatric disorders. The Company’s principal product is NeuroStar Advanced Therapy System. It is a non-invasive treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed magnetic field to induce electrical pulses for stimulating certain areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorders. The Company offers its therapy systems to psychiatrist offices in the United States.   ニュ―ロネティクスは米国の医療機器メ―カ―。主に精神障害患者の生活の質を向上するための医療機器の開発・製造・販売に従事する。同社製品ニュ―ロスタ―・アドバンスト・セラピ―・システムは、うつ病患者の治療に対して非侵襲性で、パルスMRI強度磁場を作り脳の特定領域を刺激する電流を誘導する。本社所在地はペンシルベニア州マルバ―ン。   Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Visit NeuroStar.com for safety information and indications for use. NeuroStar is also available in other parts of the world, including Japan, where it is listed under Japan's national health insurance.
本社所在地 3222 Phoenixville Pike Malvern PA 19355 USA
代表者氏名 Chris Thatcher クリス・サッチャー
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 610-640-4202
設立年月日 37712
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数
url www.neuronetics.com
nasdaq_url https://www.nasdaq.com/symbol/stim
adr_tso
EBITDA EBITDA(百万ドル) -16.16300
終値(lastsale) 27.02
時価総額(marketcap) 474931809.94
時価総額 時価総額(百万ドル) 409.89670
売上高 売上高(百万ドル) 46.00300
企業価値(EV) 企業価値(EV)(百万ドル) 614.37870
当期純利益 当期純利益(百万ドル) -21.67000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Neuronetics Inc revenues increased 31% to $23.4M. Net loss increased 76% to $13M. Revenues reflect United States segment increase of 30% to $22.9M International segment increase from $215K to $534K. Higher net loss reflects Sales and marketing - Balancing value increase of 41% to $17.8M (expense) General and administrative - Balancing increase of 65% to $5.6M (expense).

 STIMのテクニカル分析


 STIMのニュース

   A Quick Glance At Neuronetics Inc. (NASDAQ: STIM) Stock: It Is up 10.26% From Its 52-Week Low; YTD, It Is Down -30.04 Percent  2022/04/02 13:00:00 Marketing Sentinel
During the last session, Neuronetics Inc. (NASDAQ:STIM)’s traded shares were 0.34 million, with the beta value of the company hitting 2.36. At the end of the trading day, the stock’s price was $3.12, reflecting an intraday gain of 2.97% or $0.09. The 52-week high for the STIM share is $17.92, that puts it down -474.36 … A Quick Glance At Neuronetics Inc. (NASDAQ: STIM) Stock: It Is up 10.26% From Its 52-Week Low; YTD, It Is Down -30.04 Percent Read More »
   Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)  2022/03/08 21:35:00 GlobeNewswire
MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards to five new non-executive employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Neuronetics’ Compensation Committee and made as a material inducement to each employee''s entry into employment with the Company.
   Neuronetics, Inc. (STIM) Q4 2021 Earnings Call Transcript  2022/03/08 21:00:41 The Motley Fool
STIM earnings call for the period ending December 31, 2021.
   Neuronetics Posts Better Than Expected Q4 Results Despite Lower NeuroStar Therapy System Sales  2022/03/08 20:16:06 Benzinga
Neuronetics Inc (NASDAQ: STIM ) reported Q4 FY21 sales of $15.02 million , down 4% Y/Y, exceeding previously issued guidance of $13.0 million - $14.0 million and the consensus of $14.43 million. U.S. revenue decreased by 3% during the quarter, and international revenue decreased by 13% Y/Y due to lower NeuroStar Advanced Therapy System sales and treatment session … Full story available on Benzinga.com
   Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q4 2021 Earnings Call Transcript  2022/03/08 18:43:02 Seeking Alpha
   Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers  2021/07/14 12:15:00 Intrado Digital Media
The redesigned My NeuroStar Resource Center provides user-friendly tools to help practices expand awareness of NeuroStar® Advanced Therapy for Mental Health The redesigned My NeuroStar Resource Center provides user-friendly tools to help practices expand awareness of NeuroStar® Advanced Therapy for Mental Health
   Latest Research Report On Transcranial Magnetic Stimulators Market 2021. Major Players Included Neuronetics, Yiruide, Magstim, Brainsway, Neurosoft, etc.  2021/07/12 05:43:19 Tramways Monthly
The Transcranial Magnetic Stimulators Market is a rapidly growing and developing industry. This report will help you gather the information needed to either enter this space or take advantage of the many opportunities in it. DataIntelo published a great research report on the Transcranial Magnetic Stimulators Market which will help you in taking the right []
   Neuronetics to join Russell 2000 Index  2021/06/24 11:43:35 Seeking Alpha
   Neuronetics Set to Join Russell 2000® Index  2021/06/23 21:29:00 Intrado Digital Media
MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the company will be added to the Russell 2000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.
   Neuronetics Set to Join Russell 2000 Index  2021/06/23 21:29:00 Wallstreet:Online
MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the company will be added to the Russell 2000 Index at the conclusion of the 2021 Russell indexes annual
   Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting  2021/06/09 12:00:00 Intrado Digital Media
The market leader in transcranial magnetic stimulation will spotlight real-world clinical data on NeuroStar® Advanced Therapy for Mental Health The market leader in transcranial magnetic stimulation will spotlight real-world clinical data on NeuroStar® Advanced Therapy for Mental Health
   Neuronetics to Present at The JMP Securities Life Sciences Conference  2021/06/03 00:00:00 BioSpace
Neuronetics, Inc., a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer, will participate at The JMP Securities Life Sciences Conference.
   BrainsWay: Still Undervalued (Still)  2021/06/02 22:45:32 Seeking Alpha
   Appointments and advancements for June 1, 2021  2021/06/01 16:00:00 BioWorld
New hires and promotions in the med-tech industry, including: Avita Medical, Establishment Lab, Guebert, Neuronetics, RNA Disease Diagnostics, Sientra.
   Neuronetics Names Todd Cushman as Vice President, Business Development  2021/06/01 12:00:00 GlobeNewswire
With this new appointment, the market leader in transcranial magnetic stimulation will continue expanding treatment access for patients with Major Depressive Disorder With this new appointment, the market leader in transcranial magnetic stimulation will continue expanding treatment access for patients with Major Depressive Disorder

 関連キーワード  (先端医療機器_テクノロジ― 米国株 ニュ―ロネティクス STIM Neuronetics Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)